CMMI Open to Feedback, but EOM Out of the Blue

The Center for Medicare and Medicaid Innovation (CMMI) was a strong collaborator during the Oncology Care Mode (OCM), but the timing of the Enhancing Oncology Model came as a surprise.

Kashyap Patel, MD, CEO, Carolina Blood and Cancer Care Associates and president, Community Oncology Alliance, makes a point about practices that were successful under the OCM. Led by moderator Stuart Staggs, MSIE, senior director, strategic programs, The US Oncology Network, panelists Patel and Stephen Schleicher, MD, MBA, chief medical officer, Tennessee Oncology, note that community oncologists are pleased to see CMMI present the Enhancing Oncology Model (EOM), amid the setback of the COVID-19 pandemic. Schleicher said that practices await word on details of the EOM and look forward to collaborating as they did under the OCM.

Related Videos
dr mohamad mohty
Kathryn Lindley, MD, FACC
dr ryan jacobs
Video 2 - 3 KOLs are featured in, "Assessing Limitations, Costs, Mobility and Cognition in Progressive Multiple Sclerosis"
Video 1 - 3 KOLs are featured in, "Multiple Sclerosis: Impact, Types, Pathophysiology, and Progression"
Justin Oldham, MD, MS, an expert on IPF
Justin Oldham, MD, MS, an expert on IPF
Chesahna Kindred, MD, MBA, FAAD, board-certified dermatologist, Kindred Hair & Skin Cente
Related Content
CH LogoCenter for Biosimilars Logo